Ozurdex and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Ozurdex (dexamethasone), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Pantoprazole, and have Asthma.

The phase IV clinical study analyzes which people have Weakness when taking Ozurdex. It is created by eHealthMe based on reports of 2,488 people who have side effects when taking Ozurdex from the FDA, and is updated regularly.

What is Ozurdex?

Ozurdex has active ingredients of dexamethasone. eHealthMe is studying from 2,497 Ozurdex users. Check the latest studies of Ozurdex.

What is Weakness?

Weakness is found to be associated with 3,640 drugs and 6,613 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 16, 2026

2,488 people reported to have side effects when taking Ozurdex.
Among them, 17 people (0.68%) have Weakness.

Among these 17 people:

How long have people been on Ozurdex when they have Weakness? *

What is the gender of people who have Weakness when taking Ozurdex? *

female: 17.65 %
male: 82.35 %

What is the age of people who have Weakness when taking Ozurdex? *

What are other drugs people take besides Ozurdex? *

What are other side effects people have besides Weakness? *

Drowsiness: 10 people, 58.82%
Fainting (loss of consciousness and postural tone): 9 people, 52.94%
Sick Sinus Syndrome (a collection of heart rhythm disorders): 9 people, 52.94%
Nausea (feeling of having an urge to vomit): 9 people, 52.94%
High Blood Pressure: 5 people, 29.41%
Stress And Anxiety: 5 people, 29.41%
Lung Disorder (lung disease): 4 people, 23.53%
Glaucoma (increased fluid pressure in the eye with vision loss): 4 people, 23.53%
Headache (pain in head): 4 people, 23.53%
Cystoid Macular Oedema (fluid accumulation after cataract surgery): 4 people, 23.53%

What are the existing conditions these people have? *

Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 5.88%
Motion Sickness (travel sickness): 1 person, 5.88%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 1 person, 5.88%
Diabetes: 1 person, 5.88%
Cardiac Disorder: 1 person, 5.88%
Asthma: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ozurdex and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ozurdex:

Ozurdex (2,497 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Ozurdex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,640 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,613 conditions)

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Ozurdex) and Ozurdex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.